Hosier, G. W. and Touma, N. J. (2017) “Response of renal cell carcinoma to ibrutinib, a bruton tyrosine kinase inhibitor, in a patient treated for chronic lymphocytic leukemia”, Canadian Urological Association Journal, 11(5), pp. E237–9. doi: 10.5489/cuaj.4316.